CORRESP

PROKIDNEY CORP.

2000 Frontis Plaza Blvd., Ste. 250

Winston-Salem, NC 27103

September 6, 2022

VIA EDGAR

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Mail Stop 3561

Washington, D.C. 20549

 

  Re:

ProKidney Corp.

      

Registration Statement on Form S-1

      

File No. 333-266683

      

Acceleration Request

Ladies and Gentlemen:

Pursuant to Rule 461 of the Rules and Regulations promulgated under the Securities Act of 1933, as amended, ProKidney Corp. hereby requests that the effectiveness of the above-captioned Registration Statement on Form S-1 be accelerated to Thursday, September 8, 2022, at 4:00 p.m., Eastern Time, or as soon as thereafter practicable.

The cooperation of the staff in meeting the timetable described above is very much appreciated.

Any questions should be addressed to Megan Gates, Esq., at Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., One Financial Center, Boston, MA, telephone (617) 348-4443.

Thank you very much.

 

Very truly yours,
PROKIDNEY CORP.

/s/ Timothy Bertram

By: Timothy Bertram
Title: Chief Executive Officer

 

cc:

Securities and Exchange Commission

    

Daniel Crawford

    

Celeste Murphy

 

    

ProKidney Corp.

    

Timothy Bertram, Chief Executive Officer

    

James Coulston, Chief Financial Officer

    

Todd C. Girolamo, Chief Legal Officer

 

    

Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.

    

Megan Gates, Esq.